Polymorphisms of Calgranulin Genes and Ischemic Stroke in a Chinese Population

References

• Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation. 2012;125(1). e2–e220.
   PubMed Web of Science ®Google Scholar
• Boehme AK, Esenwa C, Elkind MS. Stroke risk factors, genetics, and prevention. Circ Res. 2017;120(3):472–495. doi:10.1161/CIRCRESAHA.116.308398
   PubMed Web of Science ®Google Scholar
• Donato R, Sorci G, Riuzzi F, et al. S100B’s double life: intracellular regulator and extracellular signal. Biochim Biophys Acta. 2009;1793(6):1008–1022. doi:10.1016/j.bbamcr.2008.11.009
   PubMed Web of Science ®Google Scholar
• Donato R, Cannon BR, Sorci G, et al. Functions of S100 proteins. Curr Mol Med. 2013;13(1):24–57. doi:10.2174/156652413804486214
   PubMed Web of Science ®Google Scholar
• Leclerc E, Fritz G, Vetter SW, Heizmann CW. Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta. 2009;1793(6):993–1007. doi:10.1016/j.bbamcr.2008.11.016
   PubMed Web of Science ®Google Scholar
• Cristovao JS, Gomes CM. S100 proteins in alzheimer’s disease. Front Neurosci. 2019;13:463. doi:10.3389/fnins.2019.00463
   PubMed Web of Science ®Google Scholar
• Angelopoulou E, Paudel YN, Piperi C. Emerging role of S100B protein implication in Parkinson’s disease pathogenesis. Cell Mol Life Sci. 2021;78(4):1445–1453. doi:10.1007/s00018-020-03673-x
   PubMed Web of Science ®Google Scholar
• He Y, Cai Z, Chen Y. Role of S-100beta in stroke. Int J Neurosci. 2018;128(12):1180–1187. doi:10.1080/00207454.2018.1481065
   PubMed Web of Science ®Google Scholar
• Michetti F, D’Ambrosi N, Toesca A, et al. The S100B story: from biomarker to active factor in neural injury. J Neurochem. 2019;148(2):168–187. doi:10.1111/jnc.14574
   PubMed Web of Science ®Google Scholar
• Nash DL, Bellolio MF, Stead LG. S100 as a marker of acute brain ischemia: a systematic review. Neurocrit Care. 2008;8(2):301–307. doi:10.1007/s12028-007-9019-x
   PubMed Web of Science ®Google Scholar
• Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol. 2007;81(1):28–37. doi:10.1189/jlb.0306170
   PubMed Web of Science ®Google Scholar
• Goyette J, Geczy CL. Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids. 2011;41(4):821–842. doi:10.1007/s00726-010-0528-0
   PubMed Web of Science ®Google Scholar
• Foell D, Wittkowski H, Ren Z, et al. Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease. J Pathol. 2008;216(2):183–192. doi:10.1002/path.2394
   PubMed Web of Science ®Google Scholar
• Jonsson MK, Sundlisaeter NP, Nordal HH, et al. Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis. Ann Rheum Dis. 2017;76(12):2031–2037. doi:10.1136/annrheumdis-2017-211695
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG. S100A8/A9 as a therapeutic target in myocardial infarction: cellular mechanisms, molecular interactions, and translational challenges. Eur Heart J. 2019;40(32):2724–2726. doi:10.1093/eurheartj/ehz524
   PubMed Web of Science ®Google Scholar
• Guo D, Zhu Z, Xu T, et al. Plasma S100A8/A9 concentrations and clinical outcomes of ischemic stroke in 2 independent multicenter cohorts. Clin Chem. 2020;66(5):706–717. doi:10.1093/clinchem/hvaa069
   PubMed Web of Science ®Google Scholar
• Nacken W, Roth J, Sorg C, Kerkhoff C. S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech. 2003;60(6):569–580. doi:10.1002/jemt.10299
   PubMed Web of Science ®Google Scholar
• Armstrong CW, Bosio E, Neil C, Brown SG, Hankey GJ, Fatovich DM. Distinct inflammatory responses differentiate cerebral infarct from transient ischaemic attack. J Clin Neurosci. 2017;35:97–103. doi:10.1016/j.jocn.2016.09.011
   PubMed Web of Science ®Google Scholar
• Wakisaka Y, Ago T, Kamouchi M, et al. Plasma S100A12 is associated with functional outcome after ischemic stroke: research for Biomarkers in Ischemic Stroke. J Neurol Sci. 2014;340(1–2):75–79. doi:10.1016/j.jns.2014.02.031
   PubMed Web of Science ®Google Scholar
• Zhang X, Shen R, Shu Z, Zhang Q, Chen Z. S100A12 promotes inflammation and apoptosis in ischemia/reperfusion injury via ERK signaling in vitro study using PC12 cells. Pathol Int. 2020;70(7):403–412. doi:10.1111/pin.12924
   PubMed Web of Science ®Google Scholar
• Sun X, Meng H, Shi D, et al. Analysis of plasma calprotectin and polymorphisms of S100A8 in patients with aggressive periodontitis. J Periodontal Res. 2011;46(3):354–360. doi:10.1111/j.1600-0765.2011.01350.x
   PubMed Web of Science ®Google Scholar
• Blanco-Rojo R, Delgado-Lista J, Lee Y-C, et al. Interaction of an S100A9 gene variant with saturated fat and carbohydrates to modulate insulin resistance in 3 populations of different ancestries. Am J Clin Nutr. 2016;104(2):508–517. doi:10.3945/ajcn.116.130898
   PubMed Web of Science ®Google Scholar
• Salminen A, Vlachopoulou E, Havulinna AS, et al. Genetic variants contributing to circulating matrix metalloproteinase 8 levels and their association with cardiovascular diseases: a genome-wide analysis. Circ Cardiovasc Genet. 2017;10:6. doi:10.1161/CIRCGENETICS.117.001731
   Google Scholar
• Farkas G Jr, Tiszlavicz Z, Takacs T, et al. Analysis of plasma levels and polymorphisms of S100A8/9 and S100A12 in patients with acute pancreatitis. Pancreas. 2014;43(3):485–487. doi:10.1097/MPA.0000000000000046
   PubMed Web of Science ®Google Scholar
• Li Y, Liao F, Yin XJ, et al. An association study on ADAM10 promoter polymorphisms and atherosclerotic cerebral infarction in a Chinese population. CNS Neurosci Ther. 2013;19(10):785–794.
   PubMed Web of Science ®Google Scholar
• Buck BH, Liebeskind DS, Saver JL, et al. Association of higher serum calcium levels with smaller infarct volumes in acute ischemic stroke. Arch Neurol. 2007;64(9):1287–1291. doi:10.1001/archneur.64.9.1287
   PubMedGoogle Scholar
• Sun P, Li Q, Zhang Q, Xu L, Han JY. Upregulated expression of S100A8 in mice brain after focal cerebral ischemia reperfusion. World J Emerg Med. 2013;4(3):210–214. doi:10.5847/wjem.j.issn.1920-8642.2013.03.010
   PubMedGoogle Scholar
• Shichita T, Ito M, Morita R, et al. MAFB prevents excess inflammation after ischemic stroke by accelerating clearance of damage signals through MSR1. Nat Med. 2017;23(6):723–732. doi:10.1038/nm.4312
   PubMed Web of Science ®Google Scholar
• Yan L, Bjork P, Butuc R, et al. Beneficial effects of quinoline-3-carboxamide (ABR-215757) on atherosclerotic plaque morphology in S100A12 transgenic ApoE null mice. Atherosclerosis. 2013;228(1):69–79. doi:10.1016/j.atherosclerosis.2013.02.023
   PubMed Web of Science ®Google Scholar
• Oesterle A, Bowman MA. S100A12 and the S100/calgranulins: emerging biomarkers for atherosclerosis and possibly therapeutic targets. Arterioscler Thromb Vasc Biol. 2015;35(12):2496–2507. doi:10.1161/ATVBAHA.115.302072
   PubMed Web of Science ®Google Scholar
• Croce K, Gao H, Wang Y, et al. Myeloid-related protein-8/14 is critical for the biological response to vascular injury. Circulation. 2009;120(5):427–436. doi:10.1161/CIRCULATIONAHA.108.814582
   PubMed Web of Science ®Google Scholar
• Ehlermann P, Eggers K, Bierhaus A, et al. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Cardiovasc Diabetol. 2006;5:6. doi:10.1186/1475-2840-5-6
   PubMed Web of Science ®Google Scholar
• Marta-Enguita J, Navarro-Oviedo M, Rubio-Baines I, et al. Association of calprotectin with other inflammatory parameters in the prediction of mortality for ischemic stroke. J Neuroinflammation. 2021;18(1):3. doi:10.1186/s12974-020-02047-1
   PubMed Web of Science ®Google Scholar
• Qian SQ, He SR, Li BB, Qian J, Zheng XD. Serum S100A12 and 30-day mortality after acute intracerebral hemorrhage. Clin Chim Acta. 2018;477:1–6. doi:10.1016/j.cca.2017.11.032
   PubMed Web of Science ®Google Scholar
• Singh V, Roth S, Veltkamp R, Liesz A. HMGB1 as a key mediator of immune mechanisms in ischemic stroke. Antioxid Redox Signal. 2016;24(12):635–651. doi:10.1089/ars.2015.6397
   PubMed Web of Science ®Google Scholar
• Ziegler G, Prinz V, Albrecht MW, et al. Mrp-8 and −14 mediate CNS injury in focal cerebral ischemia. Biochim Biophys Acta. 2009;1792(12):1198–1204. doi:10.1016/j.bbadis.2009.10.003
   PubMed Web of Science ®Google Scholar
• Kawano T, Shimamura M, Nakagami H, et al. Therapeutic vaccine against S100A9 (S100 calcium-binding protein A9) inhibits thrombosis without increasing the risk of bleeding in ischemic stroke in mice. Hypertension. 2018;72(6):1355–1364. doi:10.1161/HYPERTENSIONAHA.118.11316
   PubMed Web of Science ®Google Scholar
• Bjork P, Bjork A, Vogl T, et al. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides. PLoS Biol. 2009;7(4):e97. doi:10.1371/journal.pbio.1000097
   PubMed Web of Science ®Google Scholar
• Kono H, Rock KL. How dying cells alert the immune system to danger. Nat Rev Immunol. 2008;8(4):279–289. doi:10.1038/nri2215
   PubMed Web of Science ®Google Scholar
• Kim JB, Sig Choi J, Yu YM, et al. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci. 2006;26(24):6413–6421. doi:10.1523/JNEUROSCI.3815-05.2006
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu J, Chen L, et al. Genetic predisposition to ischaemic stroke by RAGE and HMGB1 gene variants in Chinese Han population. Oncotarget. 2017;8(59):100150–100164. doi:10.18632/oncotarget.22112
   PubMedGoogle Scholar